CBIO Insider Trading
Insider Ownership Percentage: 8.70%
Insider Buying (Last 12 Months): $18,237,600.00
Insider Selling (Last 12 Months): $0.00
Crescent Biopharma Share Price & Price History
Current Price: $13.17
Price Change: ▲ Price Increase of +0.1 (0.77%)
As of 12/8/2025 05:00 PM ET
Crescent Biopharma Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/4/2025 | Fairmount Funds Management Llc | Director | Buy | 1,360,000 | $13.41 | $18,237,600.00 | 2,747,866 | |
Crescent Biopharma Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/17/2025 | Citadel Advisors LLC | 25,593 | $0.30M | 0.0% | N/A | 0.184% |  |
| 11/17/2025 | Commodore Capital LP | 450,829 | $5.36M | 0.3% | -0.6% | 3.245% |  |
| 11/17/2025 | Bank of America Corp DE | 3,863 | $46K | 0.0% | -58.2% | 0.028% |  |
| 11/14/2025 | Two Sigma Investments LP | 28,318 | $0.34M | 0.0% | N/A | 0.204% |  |
| 11/13/2025 | Jefferies Financial Group Inc. | 102,714 | $1.22M | 0.0% | +279.1% | 0.739% |  |
| 11/7/2025 | Vanguard Group Inc. | 657,900 | $7.82M | 0.0% | N/A | 3.365% |  |
| 8/15/2025 | Soleus Capital Management L.P. | 400,000 | $6.46M | 0.4% | N/A | 2.046% |  |
| 8/15/2025 | Perceptive Advisors LLC | 453,686 | $7.32M | 0.7% | N/A | 2.321% |  |
| 8/15/2025 | Frazier Life Sciences Management L.P. | 453,685 | $7.32M | 0.3% | N/A | 2.321% |  |
| 8/15/2025 | Braidwell LP | 261,504 | $4.22M | 0.1% | N/A | 1.338% |  |
| 8/15/2025 | BVF Inc. IL | 1,387,863 | $22.40M | 0.8% | N/A | 7.099% |  |
| 8/15/2025 | Bank of America Corp DE | 9,231 | $0.15M | 0.0% | N/A | 0.047% |  |
| 8/15/2025 | Adage Capital Partners GP L.L.C. | 100,912 | $1.63M | 0.0% | N/A | 0.516% |  |
| 8/14/2025 | Commodore Capital LP | 453,686 | $7.32M | 0.5% | N/A | 2.321% |  |
| 8/13/2025 | Affinity Asset Advisors LLC | 280,031 | $4.52M | 0.6% | N/A | 1.432% |  |
| 8/12/2025 | Jefferies Financial Group Inc. | 27,096 | $0.44M | 0.0% | N/A | 0.139% |  |
| 8/7/2023 | Acadian Asset Management LLC | 144,028 | $50K | 0.0% | -44.5% | 0.381% |  |
| 2/15/2023 | Nantahala Capital Management LLC | 438,055 | $0.23M | 0.0% | -82.9% | 1.392% |  |
| 11/10/2022 | Nantahala Capital Management LLC | 2,554,735 | $1.29M | 0.1% | -7.3% | 8.116% |  |
| 11/7/2022 | Virtu Financial LLC | 189,175 | $95K | 0.0% | +250.5% | 0.601% |  |
| 8/15/2022 | Nantahala Capital Management LLC | 2,755,903 | $4.91M | 0.2% | +13.8% | 8.755% |  |
| 8/13/2022 | Virtu Financial LLC | 53,977 | $96K | 0.0% | N/A | 0.171% |  |
| 2/10/2022 | Acadian Asset Management LLC | 232,400 | $0.21M | 0.0% | N/A | 0.740% |  |
| 2/8/2022 | Raymond James & Associates | 32,800 | $30K | 0.0% | -74.7% | 0.104% |  |
| 2/1/2022 | Assenagon Asset Management S.A. | 512,643 | $0.47M | 0.0% | N/A | 1.632% |  |
| 11/16/2021 | Squarepoint Ops LLC | 25,527 | $0.11M | 0.0% | -45.8% | 0.081% |  |
| 11/16/2021 | Two Sigma Advisers LP | 107,000 | $0.44M | 0.0% | -30.0% | 0.341% |  |
| 11/16/2021 | Millennium Management LLC | 671,224 | $2.76M | 0.0% | -14.8% | 2.140% |  |
| 11/15/2021 | Pura Vida Investments LLC | 372,582 | $1.53M | 0.0% | N/A | 1.188% |  |
| 11/15/2021 | Dimensional Fund Advisors LP | 801,440 | $3.29M | 0.0% | -13.4% | 2.555% |  |
| 11/15/2021 | GSA Capital Partners LLP | 175,751 | $0.72M | 0.1% | +3.7% | 0.560% |  |
| 11/12/2021 | Johnson & Johnson | 66,951 | $0.28M | 0.0% | N/A | 0.213% |  |
| 11/12/2021 | Parkman Healthcare Partners LLC | 133,449 | $0.55M | 0.1% | -66.1% | 0.425% |  |
| 11/12/2021 | Stonepine Capital Management LLC | 2,635,014 | $10.83M | 4.9% | -14.3% | 8.401% |  |
| 11/12/2021 | Geode Capital Management LLC | 351,541 | $1.44M | 0.0% | +5.7% | 1.121% |  |
| 11/10/2021 | Goldman Sachs Group Inc. | 160,701 | $0.66M | 0.0% | -38.4% | 0.512% |  |
| 11/9/2021 | BlackRock Inc. | 270,718 | $1.11M | 0.0% | -4.3% | 0.863% |  |
| 11/2/2021 | Raymond James & Associates | 129,553 | $0.53M | 0.0% | -4.1% | 0.413% |  |
| 11/1/2021 | Cherry Creek Investment Advisors Inc. | 20,000 | $82K | 0.1% | N/A | 0.064% |  |
| 10/29/2021 | Commonwealth Equity Services LLC | 10,000 | $41K | 0.0% | N/A | 0.032% |  |
| 9/3/2021 | Parametric Portfolio Associates LLC | 21,019 | $91K | 0.0% | -51.9% | 0.067% |  |
| 8/16/2021 | State Street Corp | 43,399 | $0.19M | 0.0% | -88.5% | 0.138% |  |
Data available starting January 2016
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
Read More on Crescent Biopharma
Today's Range
Now: $13.17
52 Week Range
Now: $13.17
Volume
134,709 shs
Average Volume
175,172 shs
Market Capitalization
$182.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.32
Who are the company insiders with the largest holdings of Crescent Biopharma?
Who are the major institutional investors of Crescent Biopharma?
Which institutional investors are selling Crescent Biopharma stock?
Within the previous quarter, CBIO stock was sold by these institutional investors:
- Bank of America Corp DE
- Commodore Capital LP
Which institutional investors are buying Crescent Biopharma stock?
During the last quarter, CBIO stock was purchased by institutional investors including:
- Vanguard Group Inc.
- Jefferies Financial Group Inc.
- Two Sigma Investments LP
- Citadel Advisors LLC